Robert B. Naso
13Patents
6h-index
7Co-inventors
55Inventor score
Filing activity: Dec 1, 1998 → Jul 14, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6232082A | Hapten-carrier conjugates for treating and preventing nicotine addiction | Emerging Cross-Sectional Technologies | 42 | Expired |
| US7247502B2 | Hapten-carrier conjugates for treating and preventing nicotine addiction | Emerging Cross-Sectional Technologies | 31 | Expired |
| US6355625B1 | Compositions of &bgr;-glucans and specific IGIV | Human Necessities | 14 | Expired |
| US7030101B2 | Compositions of β-glucans and specific antibodies | Human Necessities | 11 | Expired |
| US6518031B2 | Hapten-carrier conjugates for treating and preventing nicotine addiction | Emerging Cross-Sectional Technologies | 8 | Expired |
| US7776620B2 | Hapten-carrier conjugates for treating and preventing nicotine addiction | Emerging Cross-Sectional Technologies | 7 | Active |
| US7550433B2 | Erythropoietin receptor peptide formulations and uses | Chemistry; Metallurgy | 3 | Active |
| US7449189B2 | Glycoconjugate vaccines for use in immune-compromised populations | Human Necessities | 2 | Active |
| US6773891B2 | Hapten-carrier conjugates for treating and preventing nicotine addiction | Emerging Cross-Sectional Technologies | 1 | Expired |
| US7919461B2 | Erythropoietin receptor peptide formulations and uses | Chemistry; Metallurgy | 0 | Active |
| US8026109B2 | Hapten-carrier conjugates for treating and preventing nicotine addiction | Emerging Cross-Sectional Technologies | 0 | Active |
| US8324159B2 | Erythropoietin receptor peptide formulations and uses | Human Necessities | 0 | Active |
| US7906485B2 | Erythropoietin receptor peptide formulations and uses | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.